Bernie Mac Sarcoidosis Translational Advanced Research (STAR) Center
About the STAR Center
Sarcoidosis is an inflammatory disease that often attacks multiple organs, particularly the lungs and lymph nodes, and disproportionately affects African Americans. Chicago comedian Bernie Mac suffered from sarcoidosis and died from complications of the disease in 2008.
The Bernie Mac STAR Center at the University of Illinois Hospital & Health Sciences System is committed to provide patients with outstanding care and to evaluate patients in a timely, compassionate and courteous manner. We provide comprehensive care for patients with all forms of sarcoidosis.
Our program is run by a multidisciplinary team made up of pulmonary and critical care physicians, rheumatologists, pharmacists, clinical nurses, research nurses and research associates. We also work closely with specialists in cardiology, ophthalmology, neurology and dermatology. Our physicians, nurses and pharmacists are experts in the care of patients with sarcoidosis. As a result of this collaborative approach, our patients receive the most comprehensive care and the benefits of cutting-edge research and state of the art treatment options available.
Since the establishment of the STAR Center in 2012, UI Health has seen a 70 percent increase in the number of sarcoidosis patients visiting the hospital for treatment.
The research objective of the Center is to develop new diagnostic, prognostic and treatment modalities for patients with sarcoidosis, and offers participation is clinical trials evaluating new therapies. The STAR Center has also played a major role in helping to reduce health disparities among sarcoidosis patients in Chicago.
Our STAR Team
- Nadera Sweiss, MD, Program Director
- Steve Dudek, MD
- Jeffrey Jacobson, MD
- Roberto Machado, MD
- Crystal Whitfield, LPN
- Maria Martinez, RN
1801 West Taylor Street, Suite 3C
Chicago, Illinois 60612
The discovery of new diagnostic, prognostic and treatment modalities for patients with sarcoidosis is a main goal of our program. With funding from the National Institutes of Health we focus on using genetic and genomic technologies to identify markers determining risk for the development of sarcoidosis, response to treatments and prognosis. With these studies we also seek to find new treatment targets for the disease. Our ultimate goal is to deliver personalized medical care to patients with sarcoidosis. We also offer participation in clinical trials evaluating new therapies for sarcoidosis.
To Make An Appointment
To make an appointment with a Sarcoidosis Specialist, call 312.413.4244.
To make an on-line appointment with Dr. Sweiss, please click here.
Confidential Voice Mail: 312.996.5723